MustGrow Biologics Corp.
MGRO.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 631.92% | 179.92% | -- | -- | -97.55% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 631.92% | 179.92% | -- | -- | -97.55% |
| Cost of Revenue | 491.40% | 693.10% | 4,036.00% | 19,182.50% | 61.04% |
| Gross Profit | -44.57% | -52.52% | 809.65% | 2,775.83% | -100.79% |
| SG&A Expenses | 44.71% | 25.70% | 83.84% | 126.24% | -5.83% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 83.68% | 58.55% | 347.13% | 382.87% | 6.22% |
| Operating Income | -22.98% | -37.85% | -4.75% | -20.13% | -128.81% |
| Income Before Tax | -73.74% | -43.13% | -12.16% | -48.95% | -134.37% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -73.74% | -43.13% | -12.16% | -48.95% | -134.37% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -73.74% | -43.13% | -12.16% | -48.95% | -134.37% |
| EBIT | -22.98% | -37.85% | -4.75% | -20.13% | -128.81% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -52.38% | -34.73% | -11.03% | -41.22% | -133.53% |
| Normalized Basic EPS | 0.95% | -35.57% | -10.59% | -40.86% | -133.55% |
| EPS Diluted | -52.38% | -34.73% | -11.03% | -41.22% | -133.53% |
| Normalized Diluted EPS | 0.95% | -35.57% | -10.59% | -40.86% | -133.55% |
| Average Basic Shares Outstanding | 14.06% | 5.94% | 0.94% | 5.70% | 2.62% |
| Average Diluted Shares Outstanding | 14.06% | 5.94% | 0.94% | 5.70% | 2.62% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |